Qingdao Haier Biomedical Co Ltd Cash Flow Conversion Efficiency
Qingdao Haier Biomedical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Qingdao Haier Biomedical Co Ltd (688139) has a cash flow conversion efficiency ratio of 0.002x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥7.33 Million ≈ $1.07 Million USD) by net assets (CN¥4.34 Billion ≈ $634.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Qingdao Haier Biomedical Co Ltd (2016–2025)
Cash flow conversion efficiency of Qingdao Haier Biomedical Co Ltd from 2016 to 2025. This chart illustrates how Qingdao Haier Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688139 stock price for real-time trading data and today's change.
Qingdao Haier Biomedical Co Ltd Cash Flow Conversion Ratio Explained
Qingdao Haier Biomedical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Qingdao Haier Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qingdao Haier Biomedical Co Ltd ranked by their cash flow conversion efficiency. Also see 688139 company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Cinda Asset Management Co., Ltd.
F:0CI
|
N/A |
|
CEAT Limited
NSE:CEATLTD
|
0.173x |
|
Tongyu Heavy Industry
SHE:300185
|
0.004x |
|
Punjab & Sind Bank
NSE:PSB
|
-0.574x |
|
Savaria Corporation
TO:SIS
|
0.048x |
|
Vaisala Oyj A
HE:VAIAS
|
0.050x |
|
Sichuan Jiuzhou Electronic Co Ltd
SHE:000801
|
0.027x |
|
China Camc Engineering Co Ltd
SHE:002051
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Qingdao Haier Biomedical Co Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Qingdao Haier Biomedical Co Ltd from 2016 to 2025. Review cash generation quality of Qingdao Haier Biomedical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥4.62 Billion ≈ $676.52 Million |
CN¥267.89 Million ≈ $39.20 Million |
0.058x | -8.25% |
| 2024-12-31 | CN¥4.62 Billion ≈ $675.78 Million |
CN¥291.67 Million ≈ $42.68 Million |
0.063x | +12.50% |
| 2023-12-31 | CN¥4.44 Billion ≈ $649.71 Million |
CN¥249.26 Million ≈ $36.48 Million |
0.056x | -63.17% |
| 2022-12-31 | CN¥4.15 Billion ≈ $607.03 Million |
CN¥632.43 Million ≈ $92.54 Million |
0.152x | -12.28% |
| 2021-12-31 | CN¥3.64 Billion ≈ $532.46 Million |
CN¥632.43 Million ≈ $92.54 Million |
0.174x | -30.53% |
| 2020-12-31 | CN¥2.78 Billion ≈ $407.46 Million |
CN¥696.62 Million ≈ $101.94 Million |
0.250x | +119.32% |
| 2019-12-31 | CN¥2.46 Billion ≈ $359.82 Million |
CN¥280.49 Million ≈ $41.04 Million |
0.114x | -14.74% |
| 2018-12-31 | CN¥1.11 Billion ≈ $162.98 Million |
CN¥149.00 Million ≈ $21.80 Million |
0.134x | -44.55% |
| 2017-12-31 | CN¥614.76 Million ≈ $89.96 Million |
CN¥148.32 Million ≈ $21.70 Million |
0.241x | -20.99% |
| 2016-12-31 | CN¥722.81 Million ≈ $105.77 Million |
CN¥220.72 Million ≈ $32.30 Million |
0.305x | -- |
About Qingdao Haier Biomedical Co Ltd
Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, and RTMD products; and CO2 incubation, standard … Read more